Jefferies upgraded Legence (LGN) to Buy from Hold with a price target of $49, up from $39. The firm’s primary concerns were alleviated with an “impressive” Q3 report as Legence “comprehensively proved” M&A value creation would not be paused but actually accelerated, and that cash generation upside could be attainable through strong working capital management, the analyst tells investors.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LGN: